No Detail Found!

Efficacy of combination therapy of pimecrolimus 1% cream and mometasone cream with either agent alone in the treatment of childhood vitiligo

Author(s)
Saeedeh Farajzadeh Department of Dermatology, Faculty of Medicine, Leishmaniasis Research Center Kerman University of Medical Sciences, Kerman, Iran
Iraj Esfandiarpour Department of Dermatology, Faculty of Medicine, Leishmaniasis Research Center Kerman University of Medical Sciences, Kerman, Iran
Elham Poor Khandani General Practitioner, Kerman, Iran
Ali Ekhlasi Dermatologist, Kerman, Iran
Soheyla Safari General Practitioner, Kerman, Iran
Sadegh Hasheminasab Gorji Dermatologist, Kerman, Iran
Mahin Aflatoonian Department of Dermatology, Faculty of Medicine, Leishmaniasis Research Center Kerman University of Medical Sciences, Kerman, Iran
Saman Mohammadi Department of Dermatology, Faculty of Medicine, Leishmaniasis Research Center Kerman University of Medical Sciences, Kerman, Iran
Maryam Khalili Department of Dermatology, Faculty of Medicine, Leishmaniasis Research Center Kerman University of Medical Sciences, Kerman, Iran
Behrooz Vares Dermatologist, Kerman, Iran
Abstract
Objective To evaluate the efficacy of the combination therapy of mometasone and pimecrolimus in the treatment of vitiligo in children. Methods In this double-blind randomized controlled trial, 50 patients were enrolled. Based on the planned treatment protocol, three lesions with approximately identical size at similar anatomic sites were selected in each patient. Lesions were divided to three groups: pimecrolimus cream 1 % (twice a day), mometasone furoate ointment 0.1 % (every night), and combined therapy group (pimecrolimus twice a day on weekdays and mometasone every night on weekends), all being applied for three months. They were followed up for three months. Results Forty patients (with 46% of cases being male) with a mean age of 10.6 years completed the study. There was no significant difference in response rate between three groups at the end of the treatment. Conclusion Our study results did not demonstrate significant difference in the response rate and adverse effects between combined treatment group and either alone.
Publication Details
Page(s) 507-513
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 28, Issue: 4, Year: 2018

Request the full text from PASTIC

Keywords
Children, mometasone, Vitiligo, Pimecrolimus
0

Citations

0

Downloads

182

Views